FR2834899B1 - Nouvelle application therapeutique des facteurs g-csf, gm-csf et scf - Google Patents

Nouvelle application therapeutique des facteurs g-csf, gm-csf et scf

Info

Publication number
FR2834899B1
FR2834899B1 FR0200611A FR0200611A FR2834899B1 FR 2834899 B1 FR2834899 B1 FR 2834899B1 FR 0200611 A FR0200611 A FR 0200611A FR 0200611 A FR0200611 A FR 0200611A FR 2834899 B1 FR2834899 B1 FR 2834899B1
Authority
FR
France
Prior art keywords
csf
scf
factors
new therapeutic
therapeutic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200611A
Other languages
English (en)
Other versions
FR2834899A1 (fr
Inventor
Didier Pourquier
Didier Moukoko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0200611A priority Critical patent/FR2834899B1/fr
Priority to PCT/FR2003/000014 priority patent/WO2003061686A1/fr
Publication of FR2834899A1 publication Critical patent/FR2834899A1/fr
Application granted granted Critical
Publication of FR2834899B1 publication Critical patent/FR2834899B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0200611A 2002-01-18 2002-01-18 Nouvelle application therapeutique des facteurs g-csf, gm-csf et scf Expired - Fee Related FR2834899B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0200611A FR2834899B1 (fr) 2002-01-18 2002-01-18 Nouvelle application therapeutique des facteurs g-csf, gm-csf et scf
PCT/FR2003/000014 WO2003061686A1 (fr) 2002-01-18 2003-01-06 Application therapeutique des facteurs g-csf, gm-csf et scf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200611A FR2834899B1 (fr) 2002-01-18 2002-01-18 Nouvelle application therapeutique des facteurs g-csf, gm-csf et scf

Publications (2)

Publication Number Publication Date
FR2834899A1 FR2834899A1 (fr) 2003-07-25
FR2834899B1 true FR2834899B1 (fr) 2005-06-10

Family

ID=27589517

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200611A Expired - Fee Related FR2834899B1 (fr) 2002-01-18 2002-01-18 Nouvelle application therapeutique des facteurs g-csf, gm-csf et scf

Country Status (2)

Country Link
FR (1) FR2834899B1 (fr)
WO (1) WO2003061686A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2139447A2 (fr) 2007-03-20 2010-01-06 Harold Brem Compositions gm-csf cosméceuticales et leurs procédés d'utilisation
WO2012048298A2 (fr) 2010-10-08 2012-04-12 Caridianbct, Inc. Procédés et systèmes de culture et de récolte de cellules dans un système de bioréacteur à fibres creuses avec conditions de régulation
EP3068867B1 (fr) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expansion de cellules dans un bioréacteur
WO2015148704A1 (fr) 2014-03-25 2015-10-01 Terumo Bct, Inc. Remplacement passif de milieu
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
WO2018184028A2 (fr) 2017-03-31 2018-10-04 Terumo Bct, Inc. Expansion cellulaire
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
JPH05506673A (ja) * 1991-02-22 1993-09-30 アムジエン・インコーポレーテツド 迅速な創傷の治癒を促進するためのｇｍ―ｃｓｆ及びｇ―ｃｓｆの使用

Also Published As

Publication number Publication date
WO2003061686A1 (fr) 2003-07-31
FR2834899A1 (fr) 2003-07-25

Similar Documents

Publication Publication Date Title
MA27192A1 (fr) Derives de n- (phenyl(piperidin-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique
IL175074A0 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatement, modification and management of pain
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
AU2003291354A1 (en) Methods and compostions for therapeutic use of rna interference
AU2002311903A1 (en) Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
HK1074792A1 (en) An anti-rheumatism medicament and method to prepare thereof
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
EP1539230A4 (fr) Administration de virus therapeutiques
FR2843964B1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
FR2834899B1 (fr) Nouvelle application therapeutique des facteurs g-csf, gm-csf et scf
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
EP1567183A4 (fr) Methodes et compositions de traitement de l'otite moyenne
ZA200503241B (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
GB0303609D0 (en) Novel therapeutic method and compositions
AU2003255612A8 (en) Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
AU2003229258A1 (en) Allergy vaccine composition, production method thereof and use of same in allergy treatment
PL359208A1 (en) New derivatives of quinosoline, method of production of new derivatives of quinosoline and pharmaceutical preparations
ITMI20021377A0 (it) Interfaccia ostointegrativa per protesi impiantabili e metodo per il trattamento di detta interfaccia ostointegrativa
AU2003214102A1 (en) N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
FR2842527B1 (fr) Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
EP1569903A4 (fr) Methodes d'utilisation d'agents inhibiteurs selectifs de la cytokine et compositions comprenant ces agents pour le traitement et la gestion de maladies myeloproliferatives
AU2003291458A8 (en) Pharmaceutical compositions and methods of using taxane derivatives
GB0303600D0 (en) Novel therapeutic method and compositions

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20160930